Mukund Chorghade's Biography

Mukund Chorghade,
President & CSO,
Chorghade Enterprises

Dr. Mukund Chorghade is a serial entrepreneur, President and Chief Scientific Officer, THINQ Pharma / THINQ Discovery, and of Chorghade Enterprises. He is the Chief Scientific Officer of Chicago Discovery Solutions, and has had Adjunct Research Professor / Visiting Fellow / Scientists appointments at Harvard, MIT, Princeton, Cambridge, Caltech, Univ. of Chicago, Northwestern, Strathclyde and several other universities. He provides synthetic chemistry and pharmaceutical drug development expertise to academic laboratories, pharmaceutical and biopharmaceutical companies. He also provides consultations on collaborations with academic, government and industrial laboratories. He establishes strategic partnerships and oversees projects in medicinal chemistry, chemical route selection, drug discovery and development. His current research interests are in Traditional Medicine derived New Chemical Entities and the discovery of the new “chemosynthetic livers” that find utility in drug metabolism, valorization of biomass and environmental remediation. He is a Certified CGLP / cGMP professional and conducts cGLP/cGMP compliance training / implementation in chemical laboratories. Dr. Chorghade earned his B. Sc. and M. Sc. degrees from the University of Poona, and a Ph. D. in organic chemistry at Georgetown University. He completed postdoctoral appointments at the University of Virginia and Harvard University, visiting scientist appointments at University of British Columbia, College de France / Universite’ Louis Pasteur, Cambridge and Caltech and directed research groups at Dow Chemicals, Abbott Laboratories, CytoMed and Genzyme. A recipient of three “Scientist of the Year Awards”, he is an elected Fellow of the ACS, AAAS, AIC and RSC and has been a featured speaker in several national and international symposia. He was privileged to become an American Chemical Society member in 1982, was section chair for Brazoria (1990) and of Northeastern Section in 2007 and is currently on the Board of Directors of the Northeastern Section. He heads the Professional Services, Public Relations Committees of the section and is an active participant in the activities of the ACS Career Services / Professional Development at the national level. He is involved with numerous activities for the IUPAC, was the Secretary of the Division on Chemistry and Human Health and served on the IUPAC Commissions on Biotechnology, Medicinal Chemistry, New Technologies and Special Topics as a Titular Member. He is currently on the US National Committee for IUPAC. He is on the Scientific Advisory Board of several corporations / foundations. He has been honored by election as a Fellow to the Maharashtra, Andhra Pradesh and Telengana Academy of Sciences, Royal Society of Chemistry (Elected Fellow); New York Academy of Sciences; American Chemical Society (Elected Fellow), American Institute of Chemists (Elected Fellow); AAAS (Elected Fellow); Sigma Xi; Indian Society of Chemists and Biologists (Elected Felow).